Skip to main content
. 2020 Nov 16;12(11):3384. doi: 10.3390/cancers12113384

Table 2.

Statistical analysis of differential protein abundance between groups.

Protein Initial St. (G2)
/Control (G1)
Advanced St. (G2)
/Control (G1)
+ Curcumin (G3)
/Initial St. (G2)
+ Curcumin (G3)
/Advanced St. (G2)
AP2S1 0.0040 0.0040 0.0003 0.0030
ARL2 0.0162 ns (0.1091) 0.0003 0.0148
DJB11 0.0040 0.0162 0.0003 0.0030
ECHA 0.0040 0.0081 0.0002 0.0011
FABP5 0.0040 0.0283 0.0002 0.0070
FINC 0.0040 0.0485 0.0019 ns (0.1605)
H2AJ 0.0040 0.0081 0.0030 ns (0.1949)
HMCS2 0.0040 ns (0.2828) 0.0002 ns (0.3823)
HNRPK 0.0040 ns (0.1091) 0.0002 0.0830
IDH3A 0.0081 ns (0.1535) 0.0006 0.0047
LYPA1 0.0040 0.0040 0.0002 0.0003
NCPR 0.0040 0.0040 0.0002 0.0002
PA2G4 0.0040 0.0162 0.0002 0.0650
PICAL 0.0081 0.0485 0.0011 0.0379
PPAC 0.0040 0.0040 0.0070 0.0104
SRSF2 0.0040 ns (0.1091) 0.0006 ns (0.2345)
VIME 0.0040 0.0162 0.0019 ns (0.5054)

Proteins for which abundance decrease or increase within the G2 group (“Tumor”) does not follow tumor progression. Nonsignificant differences (ns) are indicated in italics with calculated p values in smaller characters in brackets. Tendencies are indicated in normal type, and bold type was used to draw attention to p values < 0.05. Full names of proteins are given in Tables S1 and S2.